Diastolic heart failure and left ventricular diastolic dysfunction: What we know, and what we don't know!

International Journal of Cardiology

Volumn 115, Issue 3, 2007, Pages 284-292

  Shammas, Rony L ^a   Khan, Nazim Uddin Azam ^a   Nekkanti, Rajasekar ^a   Movahed, Assad ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Congestive heart failure; Diastolic heart failure; Left ventricular diastolic dysfunction

Indexed keywords

ALDOSTERONE ANTAGONIST; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPLERENONE; LOSARTAN; NEBIVOLOL; PERINDOPRIL; SPIRONOLACTONE; TEMOCAPRIL; VERAPAMIL;

CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; DIASTOLIC HEART FAILURE; HEART ATRIUM ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYMPTOMATOLOGY;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC OUTPUT; CARDIOTONIC AGENTS; DIASTOLE; DIGOXIN; DIURETICS; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33846849274     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.03.027     Document Type: Review

References (70)

1. AHA. Heart Disease and Stroke Statistics-2005 Update.
2. Haldeman G.A., Croft J.B., Giles W.H., and Rashidee A. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 137 (1999) 352-360
3. O'Connell J.B., and Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 13 (1994) S107-S112
4. Vasan S.R., Benjamin J.E., and Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 26 7 (1995) 1564-1574
5. Smith G.L., Masoudi F.A., Vaccarino V., Radford M., and Krumholz H. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 41 (2003) 1510-1518
6. Vasan R.S., Larson M.G., Benjamin E.J., Evans J.C., Reiss C.K., and Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33 (1999) 1948-1955
7. Colucci W.S., and Braunwald E. Pathophysiology of heart failure. In: Braunwald E. (Ed). Heart disease (1996), W.B. Saunders Co.
8. Maurer M.S., Spevack D., Burkhoff D., and Kronzon I. Diastolic dysfunction: can it be diagnosed by Doppler echocardiography?. J Am Coll Cardiol 44 (2004) 1543
9. Zile M.R., Baicu C.F., and Gaasch WH. Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. NEJM 350 (2004) 1953-1959
10. Zile M.R., and Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: Part I. Circulation 105 (2002) 1387-1393
11. Ghandi S.K., Powers J.C., Nomeir A., et al. The pathogenesis of acute pulmonary edema associated with hypertension. NEJM 344 1 (2001) 17-22
12. Kitzman D.W., Higginbothom M.B., Cobb F.R., Sheikh K.S., and Sullivan M.J. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. JACC 17 (1991) 1065-1072
13. Redfield M.M., Jacobsen S.J., Burnett Jr. J.C., Mahoney D.W., Baily K.R., and Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289 (2003) 194-202
14. Cohn J.N., Johnson G., and Veterans Administration Cooperative Study Group. Heart failure with normal ejection fraction: the V-HeFT study. Circulation 81 Suppl. III (1990) 48-53
15. Mathew S.T., Gottdiener J.S., Kitzman D., Aurigemma G., and Gardin M.J. Congestive heart failure in the elderly: the Cardiovascular Health Study. Am J Geriatr Cardiol 13 2 (2004) 61-68
16. Senni M., Tribouilloy C.M., and Rocleheffer J. Congestive heart failure in the community. A Study of all incident cases in Olmstead County, Minnesota, in 1991. Circulation 98 (1998) 2282-2289
17. Judge K.W., Pawitan Y., Caldwell J., Gersh B.J., and Kennedy W. CASS participants. J Am Coll Cardiol 18 (1991) 377-382
18. Arbab-Zadeh A., Dijk E., Prasad A., et al. Effect of aging and physical activity on left ventricular compliance. Circulation 110 (2004) 1799-1805
19. Wong W.F., Gold S., Fukuyama O., and Blanchette P.L. Diastolic dysfunction in elderly patients with congestive heart failure. Am J Cardiol 63 (1989) 1526-1528
20. Forman D.E., Coletta D., Kenny D., et al. Clinical issues related to discontinuing digoxin therapy in elderly nursing home patients. Arch Intern Med 151 (1991) 2194-2198
21. Kitzman D.W., Gardin J.M., Gottdiener J.S., et al. For the Cardiovascular Health Study Research Group. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. Am J Cardiol 87 (2001) 413-419
22. Lindenfeld J., Krause-Steinrauf H., and Salerno J. Where are all the women with heart failure?. J Am Coll Cardiol 30 (1997) 1417-1419
23. Zabalgoitia M., Ismaeil M.F., Anderson L., and Maklady F. Prevalence of diastolic dysfunction in normotensive asymptomatic patients with well-controlled type-2 diabetes mellitus. Am J Cardiol 87 (2001) 320-323
24. Miller L.W., and Missov E.D. Epidemiology of heart failure. Cardiol Clin 19 (2001) 547-555
25. Pernenkil R., Vinson J.M., Shah A.S., Beckham V., Wittenberg C., and Rich M.W. Course and prognosis in patients > or = 70 years of age with CHF and normal versus abnormal left ventricular ejection fraction. Am J Cardiol 79 (1997) 216-219
26. Yu C.M., Lin H., Yang H., Kong S., Zhang Q., and Lee S. Progression of Systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction. Circulation 105 (2002) 1195-1201
27. Niedeggen A., Breithardt O.A., and Franke A. Detection of early systolic dysfunction with strain rate imaging in a patient with light chain cardiomyopathy. Z Kardiol 94 2 (2004) 133-136
28. Mottram P.M., Haluska B., Yuda S., Leano R., and Marwick T.H. Patients with a hypertensive response to exercise have impaired systolic function without diastolic dysfunction or left ventricular hypertrophy. J Am Coll Cardiol 19 (2004) 430-436
29. Fang Z.Y., Leano R., and Marwich T.H. Relationship between longitudinal and radial contractility in subclinical diabetic heart disease. Clin Sci 106 (2004) 53-60
30. European study group on diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 19 (1998) 990-1003
31. Vasan R.S., and Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 101 (2000) 2118-2121
32. Feigenbaum H. Evaluation of systolic and diastolic function of the left ventricle. In: Feigenbaum H., Armstrong W.F., and Ryan T. (Eds). Feigenbaum's echocardiography (2005), Lippincott Williams & Wilkins, Philadelphia 138-180
33. Rosvoll O., and Hatle L.K. Pulmonary venous flow velocities recorded by transthoracic Doppler ultrasound: relation to left ventricular diastolic pressures. J Am Coll Cardiol 21 (1993) 1687-1696
34. Ommen S.R., Nishimura R.A., Appleton C.P., et al. Clinical utility of Doppler echo and tissue Doppler imaging in the estimation of left ventricular filling pressures. A comparative simultaneous Doppler. Circulation 102 (2000) 1788-1794
35. Zile M.R., Gaasch W.H., Carroll J.D., et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?. Circulation 104 (2001) 779-782
36. Tsang T.S., Barnes M.E., Gersh B.J., Bailey K.R., and Seward J.B. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90 (2002) 1284-1296
37. Arques S., Ambrosi P., Gelisse R., Roux E., Lambert M., and Habib G. Prevalence of angiographic coronary artery disease in patients hospitalized for acute diastolic heart failure without clinical and electrocardiographic evidence of myocardial ischemia on admission. Am J Cardiol 94 (2004) 133-135
38. Nakagawa O., Ogawa Y., Itoh H., Suga S., Komatsu Y., and Kishimoto I. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. J Clin Invest 96 (1995) 1280-1287
39. Liang F., and Gardner D.G. Mechanical strain activates BNP gene transcription through a p38/NF-kB-dependent mechanism. J Clin Invest 104 (1999) 1603-1612
40. Yamaguchi H., Yoshida J., Yamamoto K., et al. Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol 43 (2004) 55-60
41. Alehagen U., Eriksson H., Nylander E., and Dahlstrom U. Heart failure in the elderly; characteristics of a Swedish primary health care population. Heart Drug 2 (2002) 211-220
42. Mottram P.M., Haluska B.A., and Marwick T.H. Response of B-type natriuretic peptide to exercise in hypertensive patients with suspected diastolic heart failure: correlation with cardiac function, hemodynamics and workload. Am Heart J 148 (2004) 365-370
43. Dahlstrom U. Can natriuretic peptides be used for the diagnosis of diastolic heart failure?. Eur J Heart Fail 6 (2004) 281-287
44. Bibbins-Domingo K., Ansari M., Schiller N.B., Massie B., and Whooley M.A. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the heart and soul study. Circulation 108 (2003) 2987-2992
45. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 44 (2004) 1988-1995
46. Goetz J.P., Christofferson C., Perko M., et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 17 (2003) 1105-1107
47. Chen H.H., Lalnchbury J.G., and Redfield M.M. Factors influencing survival of patients with diastolic heart failure in Olmstead County MN in 1996-1997. Circulation 102 Suppl. II (2000) 412
48. Rich M.W., McSherry F., Williford W.O., and Yusuf S. Effect of age on mortality, hospitalizations, and response to digoxin in patients with heart failure: the DIG study. J Am Coll Cardiol 38 (2001) 806-813
49. Setaro J.F., Soufer R., Remetz M.S., Perlmutter R.A., and Zaret B.L. Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance. Am J Cardiol 69 (1992) 1212-1216
50. Brogan III W.C., Hillis L.D., Flores E.D., and Lange R.A. The natural history of isolated left ventricular diastolic dysfunction. Am J Med 92 (1992) 627-630
51. East M.A., Peterson E.D., Shaw L.K., Gattis W.A., and O'Connor C.M. Racial differences in the outcomes of patients with diastolic heart failure. Am Heart J 148 (2004) 151-156
52. Yusuf S., Pfeffer M.A., Swedberg K., et al. Effects of Candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial. Lancet 362 (2003) 777-781
53. Wachtell K., Bella J.N., Rokkedal J., et al. Change in diastolic left ventricular filling after one year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in Hypertension (LIFE) study. Circulation 105 (2002) 1071-1076
54. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336 (1997) 525-533
55. Bergstrom A., Andersson B., Edner M., Nylander E., Persson H., and Dahlstrom U. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Eur J Heart Fail 6 4 (2004 (Jun)) 453-461
56. Flather M.D., Shibata M.C., Coats A.J.S., et al. Randomized trial to determine the effect of Nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26 (2005) 215-225
57. Schmieder R.E., Messerli F.H., Garavaglia G.E., and Nunez B.D. Cardiovascular effects of verapamil in patients with essential hypertension. Circulation 75 (1987) 1030-1036
58. Amodeo C., Kobrin I., Ventura H.O., Messerli F.H., and Frohlich E.D. Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension. Circulation 73 (1986) 108-113
59. Setaro J.F., Zaret B.L., Schulman D.S., Black H.R., and Soufer R. Usefulness of Verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 66 (1990) 981-986
60. Nishikawa N., Masuyama T., and Yamamoto K. Long-term administration of amlodipine prevents decompensation to diastolic heart failure in hypertensive rats. J Am Coll Cardiol 38 (2001) 1539-1545
61. Cleland J.G., Tendera M., Adamus J., et al. Perindopril for elderly people with chronic heart failure: the PEP-CHF study. Eur J Heart Fail 1 (1999) 211-217
62. Sheiban I., Arcaro G., Covi G., Accardi R., Zenorini C., and Lechi A. Regression of cardiac hypertrophy after antihypertensive therapy with nifedipine and captopril. J Cardiovasc Pharmacol 10 Suppl. 10 (1987) 187-191
63. Grandi A.M., Venco A., Barzizza F., Casadei B., Marchesi E., and Finardi G. Effect of enalapril on left ventricular mass and performance in essential hypertension. Am J Cardiol 63 (1989) 1093-1097
64. Philbin E.F., Rocco T.A., Lindenmuth N.W., and Jenkins P.L. Angiotensin converting enzyme inhibitor use in diastolic heart failure is associated with a reduced risk of death. JACC (2000) 232A
65. Warner J.G., Metzger C., Kitzman D.W., Wesley D.J., and Little W.C. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. Am J Cardiol 33 (1999) 1567-1572
66. Yoshida J., Yamamoto K., Mano T., et al. AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure. Hypertension 43 (2004) 686-691
67. Pitt B., Zannad F., Remme W., et al. For the Randomized Aldactone Evaluation Study (RALES) investigators. N Engl J Med 341 (1999) 709-717
68. Zannad F., Alla F., Dousset B., Perez A., and Pitt B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the Randomized Aldactone Evaluation Study (RALES). Circulation 102 (2000) 2700-2706
69. Pitt B., Reichek N., Willenbrock R., et al. Effects of Eplerenone, Enalapril and Eplerenone/Enalapril in patients with essential hypertension and left ventricular hypertrophy. The 4E-left ventricular hypertrophy study. Circulation 108 (2003) 1831-1838
70. Masson S., Staszewsky L., Annoni G., et al. Eplerenone, a selective aldosterone blocker, improves diastolic function in aged rats with small to moderate myocardial infarction. J Card Fail 10 (2004) 433-441